Donald Trump and media commentators discuss the rebranding of third vaccine doses as "boosters," suggesting it is a multi-billion dollar profit scheme for Pfizer. A producer in the pharmaceutical field clarifies that boosters are being pushed to sell new stock rather than to use up expiring doses.


